| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 61 | Beneficial strains in the biological-derived Lactobacillus salivarius and it from the resulting antimicrobial agent | JP53406598 | 1998-02-11 | JP4743925B2 | 2011-08-10 | ジェラルド クリストファー オサリヴァン; マリアン メアリー ジェラルダン オサリヴァン; ジョン ケヴィン コリンズ; ジェラルダン メアリー ソーントン |
| A strain of Lactobacillus salivarius isolated from resected and washed human gastrointestinal tract inhibits a broad range of Gram positive and Gram negative microorganisms and secretes a product having antimicrobial activity into a cell-free supernatant. The activity is produced only by growing cells and is destroyed by proteinase K and pronase E, the inhibitory properties of the strain and its secretory products being maintained in the presence of physiological concentrations of human bile and human gastric juice. The strain exhibits a broad-spectrum of activity against bacteria including Listeria, Staphylococcus, including methocillin resistant St. aureus (MRSA), and Bacillus, but does not inhibit many closely related lactobacilli. An antimicrobial agent is obtained from the strain which has bacteriocin-like properties. | ||||||
| 62 | Bifidobacterium in inflammatory disease therapy (Bifidobacterium) | JP2000593725 | 2000-01-17 | JP4706016B2 | 2011-06-22 | オサリバン，ジェラルド，クリストファー; オマホニー，リアム; コリンズ，ジョン，ケビン; シャナハン，フェルグス |
| A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the prophylaxis and/or treatment of undesirable inflammatory activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may also be due to cancer. | ||||||
| 63 | Lactobacillus isolated strain having anti-inflammatory activity and use thereof | JP2008331809 | 2008-12-26 | JP2009269906A | 2009-11-19 | YU TU-WEN; LI JUN-SHENG; HSIEH FENG-CHING; CHEN CHING-PEI; HUANG TSUEI-YIN; LU YING-CHEN |
| PROBLEM TO BE SOLVED: To provide the disclosure and utilization of two Lactobacillus isolated strains having anti-inflammatory activities and beneficial probiotic properties, i.e., Lactobacillus sakei GMNL-76 and Lactobacillus reuteri GMNL-89. SOLUTION: The above-described bacterial strains have been discriminated from natural world and deposited in the Biosource Collection and Research Center (BCRC) under accession numbers BCRC 910355 and BCRC 910340 and in the China Center for Type Culture Collection (CCTCC) under accession numbers CCTCC M207153 and CCTCC M207154, respectively. With respect to backward generations subjected to subculture with the bacterial strains, examples of application to a foodstuff and a pharmaceutical compound are indicated. COPYRIGHT: (C)2010,JPO&INPIT | ||||||
| 64 | Method of manufacturing Fisheries fermented food | JP2001238004 | 2001-08-06 | JP4243442B2 | 2009-03-25 | 信彦 堂本; 隆史 森 |
| 65 | Viable formulations and lactic acid bacteria-containing foods as an active ingredient a lactic acid bacteria | JP2003579579 | 2002-03-29 | JP4203855B2 | 2009-01-07 | 泰裕 古賀 |
| Disclosed is a live bacterium preparation or food containing a lactic acid bacterium comprising a lactic acid bacterium, Lactobacillus salivarius, as an active ingredient. There is provided a live bacterium preparation and food containing a lactic acid bacterium that can prevent onset, recurrence and exacerbation of periodontal disease and/or dental caries caused by periodontopathic bacteria and cariogenic bacteria and can prevent generation of halitosis and maintain pH of saliva at a physiologically normal level by normalizing intraoral microflora. | ||||||
| 66 | Probiotic strain, the selection method, its composition, and its use | JP2004516689 | 2003-06-26 | JP2005536197A | 2005-12-02 | フアン、ミゲル、ロドリゲス、ゴメス; フリオ、ボサ、プエルタ; ヘスス、ヒメネス、ロペス; ホルディ、サウス、ペイ; ロシオ、マルティン、ヒメネス |
| 本発明は、以下の工程：
ａ． 母乳および／または羊水中で生存できる非病原性菌株の選択、およびｂ． 健常人が経口摂取した後に、粘膜を除く他の内臓に定着することなく母乳および／または羊水中に移行され得る非病原性菌株の選択からなる、新規プロバイオティクス菌株を選択するための新規方法に関する。 本発明はまた、新規ラクトバチルス菌株：ＣＥＣＴ５７１１（ラクトバチルス・コリニフォルミス）、ＣＥＣＴ５７１３（ラクトバチルス・サリバリウス亜種サリバリウス）、ＣＥＣＴ５７１４：（ラクトバチルス・ガセリ、以前はＬ．アシドフィラス）、ＣＥＴＣ５７１５：（ラクトバチルス・ガセリ）、およびＣＥＣＴ５７１６：（ラクトバチルス・ファーメンタム）を提供し、また消化器疾患、感染症、神経変性疾患、およびアレルギーなどの免疫関連疾患または炎症性疾患の予防または処置のためのそれらの使用にも関する。 |
||||||
| 67 | 水産発酵食品の製造方法 | JP2003518306 | 2002-08-05 | JPWO2003013281A1 | 2004-11-25 | 堂本 信彦; 信彦 堂本; 隆史 森; 雅之 那須 |
| 魚肉を原料にして、乳酸発酵によって付与される特有の味・風味を有し、畜肉様の食感を持つ新規な魚肉発酵食品を提供すること。魚介類を乳酸発酵するに際し、10℃以下で発酵し耐塩性抗菌性を有する乳酸菌を用いることを特徴とする水産加工製品の製造法。10℃以下で発酵し、耐塩性、抗菌性を有する乳酸菌が、ロイコノストック属(Leuconostoc)、ラクトバチルス属(Lactobacillus)、ラクトコッカス属(Lactococcus)およびペディオコッカス属(Pediococcus)からなる群から選ばれる属に属する乳酸菌である。ラクトバチルス属(Lactobacillus)に属する乳酸菌が、ラクトバチルス・サケ(Lactobacillussake)に属する乳酸菌、好ましくはラクトバチルス・サケ(Lactobacillussake)D−1001(微工研菌寄第11708号)である。10℃以下で発酵させ、その後、燻煙、乾燥を行う水産加工製品の製造法。上記の製造法で製造された水産加工製品。 | ||||||
| 68 | Fermented infant formula with non digestible oligosaccharides | US14407907 | 2013-06-14 | US09617327B2 | 2017-04-11 | Thomas Ludwig; Sylvie Huybers; Evan Abrahamse; Houkje Bouritius |
| The present invention relates to a fermented infant formulae comprising non digestible oligosaccharides for improving intestinal tract health by decreasing protein digestive effort, by decreasing the amount of endogenously formed proteases concomitant with an increased protein digestion, and a reduced protein fermentation. | ||||||
| 69 | METHOD FOR REDUCING THE CONTENT OF PATHOGENIC ORGANISMS PRESENT IN FOOD MATERIALS | US15359197 | 2016-11-22 | US20170071237A1 | 2017-03-16 | MARIE LOUISE HELLER STAHNKE |
| The present invention relates to a method for reducing the concentration of pathogenic organisms such as Listeria spp. in fermented food products. The method comprises the steps of: (i) providing a food material, (ii) mixing said food material with a starter culture, (iii) mixing the food material with at least one adjunct culture in form of a bacteriocin-producing Pediococcus species, (iv) subjecting the mixture provided in step (iii) to a fermentation process, said fermentation process being con-ducted at conditions that are sub-optimal for growth of the bacteriocin-producing Pediococcus species in order to provide a limited acidification and allow for a high production of bacteriocin, and obtain a fermented food product. Furthermore, the invention relates to the use of bacteriocin-producing Pediococcus species as an adjunct culture for securing microbial safety of fermented food products. | ||||||
| 70 | METHOD FOR PREPARING CHEESES WITH IMPROVED AROMA | US14411902 | 2013-07-05 | US20150147437A1 | 2015-05-28 | Elise Manoury; Véronique Laffitte |
| The present invention provides a method for preparing fermented milk products, especially cheeses such as foil-ripened cheeses, wherein said cheeses have a sulphur aroma. | ||||||
| 71 | FERMENTED INFANT FORMULA WITH NON DIGESTIBLE OLIGOSACCHARIDES | US14407907 | 2013-06-14 | US20150132365A1 | 2015-05-14 | Thomas Ludwig; Sylvie Huybers; Evan Abrahamse; Houkje Bouritius |
| The present invention relates to a fermented infant formulae comprising non digestible oligosaccharides for improving intestinal tract health by decreasing protein digestive effort, by decreasing the amount of endogenously formed proteases concomitant with an increased protein digestion, and a reduced protein fermentation. | ||||||
| 72 | Method for processing of fish egg and processed fish egg produced by the method | US12527768 | 2008-02-19 | US08535742B2 | 2013-09-17 | Yoichi Suzuki; Izumi Sakagami |
| Provided are a method of processing fish eggs, which can produce fish eggs having a good color tone without using a color-developing agent such as a nitrite or by using a reduced amount of the color-developing agent, and processed fish eggs produced by the method. A lactic acid bacterium, which can improve the color tone of the fish eggs, is added to the fish eggs. The lactic acid bacterium is preferably a lactic acid bacterium belonging to the genus Lactobacillus or Carnobacterium, more preferably Lactobacillus coryniformis K12 (Deposition Number: FERM BP-10945) or Carnobacterium maltaromaticum B64 (Deposition Number: FERM BP-10449). | ||||||
| 73 | Anti-allergy lactic acid bacteria | US11937429 | 2007-11-08 | US08021868B2 | 2011-09-20 | Wei-Chih Su; Pei-Shan Hsieh; Yi-Chun Tsai; Chyi-Jang Wu; Yi-Chun Chen; Chung-Wei Kuo; Chiung-Ying Yang |
| The invention described relates to novel strains of lactic acid bacteria and their use in anti-allergy. The composition may be in the form of foodstuffs or in the form of pharmaceutical compositions. | ||||||
| 74 | Lactobacillus isolates having anti-inflammatory activities and uses of the same | US12340081 | 2008-12-19 | US07901926B2 | 2011-03-08 | Tu-Wen Yu; Jun-Sheng Li; Feng-Ching Hsieh; Ching-Pei Chen; Tsuei-Yin Huang; Ying-Chen Lu |
| Disclosed herein are two Lactobacillus isolates having anti-inflammatory activities and beneficial probiotic properties, i.e., Lactobacillus sakei GMNL-76 and Lactobacillus reuteri GMNL-89, which were deposited in the Biosource Collection and Research Center (BCRC) of the Food Industry Research and Development Institute (FIRDI) under accession numbers BCRC 910355 and BCRC 910340 and in the China Center for Type Culture Collection (CCTCC) under accession numbers CCTCC M 207153 and CCTCC M 207154, respectively. The two Lactobacillus isolates and their sub-cultured offspring can be used in the preparation of a variety of food products, and in the manufacture of pharmaceutical compositions for treating and/or alleviating diseases associated with inflammation, such as rheumatoid arthritis. | ||||||
| 75 | PROBIOTICS FOR INDUCING SATIETY AND/OR SATIATION | US12670537 | 2007-07-25 | US20100203026A1 | 2010-08-12 | Marta Zdzislawa Korczynska; Wouter Noordman; Arthur Constantijn Ouwehand |
| The invention relates to the field of nutrition and medicine. Provided are compositions, bacterial strains and methods for inducing or enhancing satiety and satiation and for treating or preventing obesity, overweight and overweight related diseases. | ||||||
| 76 | Live bacterium preparation containing lactic acid bacterium as active ingredient and food containing lactic acid bacterium | US10508340 | 2002-03-29 | US07674613B2 | 2010-03-09 | Yasuhiro Koga |
| Disclosed is a live bacterium preparation or food containing a lactic acid bacterium comprising a lactic acid bacterium, Lactobacillus salivarius, as an active ingredient. There is provided a live bacterium preparation and food containing a lactic acid bacterium that can prevent onset, recurrence and exacerbation of periodontal disease and/or dental caries caused by periodontopathic bacteria and cariogenic bacteria and can prevent generation of halitosis and maintain pH of saliva at a physiologically normal level by normalizing intraoral microflora. | ||||||
| 77 | Use of Specific Lactic Bacteria for the Preparation of Immunomodulating Compositions | US11989761 | 2006-07-31 | US20090104168A1 | 2009-04-23 | Giancarla Dondi; Patrizia Malfa |
| The invention concerns the use of two lactobacteria for the preparation of immunomodulating compositions, in particular for the treatment and/or prevention of allergies and immunodeficiencies, and specifically use of the following two strains Lactobacillus salivarius I 1794 and Lactobacillus paracasei I 1688, alone or in combination, in the treatments indicated above. | ||||||
| 78 | Probiotic strains, a process for the selection of them, compositions thereof, and their use | US11024370 | 2004-12-28 | US07468270B2 | 2008-12-23 | Jordi Xaus Pei; Rocío Martin Jiménez; Juan Miguel Rodríguez Gómez; Julio Boza Puerta; Jesús Jiménez López |
| The present invention relates to a novel process for the selection of new probiotic strains which comprises the following steps: a) selecting for non-pathogenic strains which are capable of surviving in breast milk and/or amniotic fluid, and b) selecting for non-pathogenic strains which are able to be transferred to breast milk and/or amniotic fluid after oral intake in healthy individuals without colonizing other internal organs except mucousas. The invention also provides new Lactobacillus strains, which are: CECT5711 (Lactobacillus coryniformis), CECT5713 (Lactobacillus salivarius subsp. salivarius), CECT5714: (Lactobacillus gasseri, formerly L. acidophilus), CETC5715: (Lactobacillus gasseri), and CECT5716: (Lactobacillus fermentum); and refers to their use for the prophylaxis or treatment against digestive, infective, neuro-degenerative and immune related diseases such as allergies or inflammatory diseases. | ||||||
| 79 | Method for Reducing the Content of Pathogenic Organisms Present in Food Materials | US11578331 | 2005-04-15 | US20080102159A1 | 2008-05-01 | Marie Louise Heller Stahnke |
| The present invention relates to a method for reducing the concentration of pathogenic organisms such as Listeria spp. in fermented food products. The method comprises the steps of: (i) providing a food material, (ii) mixing said food material with a starter culture, (iii) mixing the food material with at least one adjunct culture in form of a bacteriocin-producing Pediococcus species, (iv) subjecting the mixture provided in step (iii) to a fermentation process, said fermentation process being conducted at conditions that are sub-optimal for growth of the bacteriocin-producing Pediococcus species in order to provide a limited acidification and allow for a high production of bacteriocin, and obtain a fermented food product. Furthermore, the invention relates to the use of bacteriocin-producing Pediococcus species as an adjunct culture for securing microbial safety of fermented food products. | ||||||
| 80 | Bifidobacterium in the treatment of inflammatory disease | US11699115 | 2007-01-29 | US20080057109A1 | 2008-03-06 | John Collins; Gerald O'Sullivan; Liam O'Mahony; Fergus Shanahan |
| A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the prophylaxis and/or treatment of undesirable inflammatory activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may also be due to cancer. | ||||||
QQ群二维码
意见反馈
意见反馈